★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarkets Discounted Biotech Sellers, Rich Pharma Buyers May Finally Revive M&A Activity in Healthcare The acquisition of biotechnology firms is one of the most common ways big pharma replenishes their pipeline of new drugs. However,…McAlinden Research PartnersMay 12, 2022
★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareServicesTechnology Digital Health Funding Shatters Annual Record, AI and Tech Wearables Key for Year Ahead Digital health continues to garner significant investor interest as startups across the industry raked in a record-breaking $29.1 billion last…McAlinden Research PartnersJanuary 18, 2022
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Evolving COVID Variants May Render Current Treatments Obsolete, Drive Need for New Round of Therapeutics The COVID-19 omicron variant has diminished the efficacy of the US's most prominent antibody treatments. As the genome of this virus constantly…McAlinden Research PartnersJanuary 4, 2022
★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarkets Biotech, Pharma Cash Piles set to Drive Dealmaking and Buyback Activity in 2022 Most data indicates M&A activity has slowed in the pharmaceutical and biotech industries. However, that may change in 2022 as…McAlinden Research PartnersDecember 22, 2021
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Drug StoresMarketsServices Drug Stores Push Further into Healthcare as Primary Care Services Prove to be New Path Forward US drug store chains are set to experience heightened foot traffic now that all adults are eligible for booster shots…McAlinden Research PartnersNovember 29, 2021
★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcarePolitics & Policy Psychedelic Drug Trials Accelerate as Decriminalization Spreads, Investment Expands Psychedelic drugs and therapies continue to show promise as a form of treatment for a wide variety of mental health disorders.…McAlinden Research PartnersOctober 18, 2021
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Drug StoresMarketsServices Drug Stores Prep For Booster Shot Drive, Look Toward Healthcare For Longer Term Profitability Drug stores could be set to boost their revenues as COVID-19 restrictions ease and vaccine booster shot plans continue to…McAlinden Research PartnersOctober 4, 2021
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Gene Editing Firms Expand Potential Treatments by Shrinking Proteins, Focusing on RNA Research Research into CRISPR gene editing technology continues to expand the amount of potential applications, while shrinking the actual size of proteins…McAlinden Research PartnersSeptember 8, 2021
★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarkets AI Promises to Accelerate Drug Discovery, Streamline Biotech Breakthroughs AI is transforming industries across every sector of the economy. Biotech and pharma are now experiencing a boom in AI initiatives…McAlinden Research PartnersJuly 27, 2021
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Gene Editing May Terminate Virus Transmission, Combat Heart and Brain Disease With a Single Shot Promising developments in new gene editing trials continue to drive investor interest in the growing biotech sector. Potential advancements include the…McAlinden Research PartnersJuly 22, 2021